Arbutus Biopharma

In News

After $178M payoff from Moderna, Arbutus BioPharma expands patent litigation against Pfizer and BioNTech - The Business Journals

The Business Journals - Jul 16, 2026

Arbutus Biopharma Files International Patent Lawsuits Against Pfizer and BioNTech, Announces Moderna Settlement Payment and Plans for Capital Return - Quiver Quantitative

Quiver Quantitative - Jul 16, 2026

Arbutus Biopharma, Genevant Sue Pfizer, BioNTech Over Lipid Nanoparticle Patents - Moomoo

Moomoo - Jul 16, 2026

Arbutus Biopharma (Nasdaq: ABUS) receives $178M from Moderna, eyes $230M buyback - Stock Titan

Stock Titan - Jul 16, 2026

ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? - Yahoo Finance

Yahoo Finance - Jul 16, 2026

Arbutus Biopharma: Moderna Validates My IP Bull Case (NASDAQ:ABUS) - Seeking Alpha

Seeking Alpha - Jul 13, 2026

Arbutus Biopharma (ABUS) Files Lawsuits Against Pfizer and BioNT - GuruFocus

GuruFocus - Jul 16, 2026

Arbutus initiates patent infringement actions against Pfizer and BioNTech - The Pharma Letter

The Pharma Letter - Jul 16, 2026

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents - marketscreener.com

marketscreener.com - Jul 16, 2026

Arbutus Biopharma (ABUS) Stock Looks Reasonable On Earnings But Stretched On Value - simplywall.st

simplywall.st - Jul 09, 2026

Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences - European AIDS Treatment Group

European AIDS Treatment Group - Apr 15, 2026

ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? - Stocktwits

Stocktwits - Jul 16, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment